Aim At Melanoma
EIN: 562427805 · Sacramento, CA · NTEE: G30
| Metric | Value |
|---|---|
| Total Revenue | $3.1M |
| Total Expenses | $2.3M |
| Net Assets | $6.0M |
Is Aim At Melanoma Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Aim At Melanoma
Aim At Melanoma (EIN: 562427805) is a nonprofit organization based in Sacramento, CA, classified under NTEE code G30. The organization reported total revenue of $3.1M and total assets of $6.7M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Aim At Melanoma's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Aim At Melanoma is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 8.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $3.2M |
| Total Expenses | $2.3M |
| Surplus / Deficit | +$932K |
| Total Assets | $6.0M |
| Total Liabilities | $18K |
| Net Assets | $6.0M |
| Operating Margin | 28.7% |
| Debt-to-Asset Ratio | 0.3% |
| Months of Reserves | 31.2 months |
Financial Health Grade: A
In 2023, Aim At Melanoma reported a surplus of $932K with revenue exceeding expenses, holds 31.2 months of operating reserves (strong position), has a debt-to-asset ratio of 0.3% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Aim At Melanoma's revenue has grown at a compound annual growth rate (CAGR) of 8.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +25.5% | +5.4% | +18.5% |
| 2022 | -10.9% | +19.1% | +8.4% |
| 2021 | +24.2% | +1.3% | +27.6% |
| 2020 | -9.2% | -10.7% | +13.8% |
| 2019 | +1.1% | -14.0% | +25.4% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Aim At Melanoma has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Aim At Melanoma with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $932K, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.3%.
Frequently Asked Questions about Aim At Melanoma
Is Aim At Melanoma a legitimate charity?
Aim At Melanoma (EIN: 562427805) is a registered tax-exempt nonprofit based in California. It has 13 years of IRS 990 filings on record. Total revenue: $3.1M. No red flags identified. Financial health grade: A.
How does Aim At Melanoma spend its money?
Aim At Melanoma reported $3.1M in total revenue in IRS 990 filings. 13 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Aim At Melanoma tax-deductible?
Aim At Melanoma is registered as a tax-exempt nonprofit (EIN: 562427805). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Aim At Melanoma located?
Aim At Melanoma is headquartered in Sacramento, California and files with the IRS under EIN 562427805. It is classified under NTEE code G30.
How many years of IRS 990 filings does Aim At Melanoma have?
Aim At Melanoma has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $3.1M in total revenue.
Filing History
IRS 990 filing history for Aim At Melanoma showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Aim At Melanoma's revenue has grown by 160.4%, moving from $1.2M to $3.2M. Total assets increased by 620.7% over the same period, from $836K to $6.0M. Total functional expenses rose by 165.5%, from $871K to $2.3M. In its most recent filing year (2023), Aim At Melanoma reported a surplus of $932K, with revenue exceeding expenses. The organization holds $18K in liabilities against $6.0M in assets (debt-to-asset ratio: 0.3%), resulting in net assets of $6.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $3.2M | $2.3M | $6.0M | $18K | — | — |
| 2022 | $2.6M | $2.2M | $5.1M | $8K | — | View 990 |
| 2021 | $2.9M | $1.8M | $4.7M | $6K | — | View 990 |
| 2020 | $2.3M | $1.8M | $3.7M | $50K | — | — |
| 2019 | $2.6M | $2.0M | $3.2M | $122K | — | View 990 |
| 2018 | $2.5M | $2.4M | $2.6M | $0 | — | View 990 |
| 2017 | $2.4M | $2.1M | $2.4M | $0 | — | View 990 |
| 2016 | $1.8M | $1.4M | $2.1M | $0 | — | View 990 |
| 2015 | $1.7M | $1.3M | $1.7M | $0 | — | View 990 |
| 2014 | $1.3M | $1.2M | $1.3M | $0 | — | View 990 |
| 2013 | $1.2M | $1.2M | $1.2M | $0 | — | View 990 |
| 2012 | $1.2M | $866K | $1.1M | $0 | — | View 990 |
| 2011 | $1.2M | $871K | $836K | $3K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $3.2M, expenses of $2.3M, and assets of $6.0M (revenue +25.5% year-over-year).
- 2022: Revenue of $2.6M, expenses of $2.2M, and assets of $5.1M (revenue -10.9% year-over-year).
- 2021: Revenue of $2.9M, expenses of $1.8M, and assets of $4.7M (revenue +24.2% year-over-year).
- 2020: Revenue of $2.3M, expenses of $1.8M, and assets of $3.7M (revenue -9.2% year-over-year).
- 2019: Revenue of $2.6M, expenses of $2.0M, and assets of $3.2M (revenue +1.1% year-over-year).
- 2018: Revenue of $2.5M, expenses of $2.4M, and assets of $2.6M (revenue +5.3% year-over-year).
- 2017: Revenue of $2.4M, expenses of $2.1M, and assets of $2.4M (revenue +35.5% year-over-year).
- 2016: Revenue of $1.8M, expenses of $1.4M, and assets of $2.1M (revenue +8.0% year-over-year).
- 2015: Revenue of $1.7M, expenses of $1.3M, and assets of $1.7M (revenue +24.9% year-over-year).
- 2014: Revenue of $1.3M, expenses of $1.2M, and assets of $1.3M (revenue +6.4% year-over-year).
- 2013: Revenue of $1.2M, expenses of $1.2M, and assets of $1.2M (revenue +7.8% year-over-year).
- 2012: Revenue of $1.2M, expenses of $866K, and assets of $1.1M (revenue -7.5% year-over-year).
- 2011: Revenue of $1.2M, expenses of $871K, and assets of $836K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Aim At Melanoma:
Data Sources and Methodology
This transparency report for Aim At Melanoma is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.